PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Public ClinicalTrials.gov record NCT00048230. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An International, Multi-Center, Randomized, Open-Label Study of PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will compare the efficacy of PS-341 versus high dose dexamethasone.
Study identification
- NCT ID
- NCT00048230
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 620 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2002
- Primary completion
- Jun 30, 2004
- Completion
- Nov 30, 2004
- Last update posted
- Jan 12, 2012
2002 – 2004
United States locations
- U.S. sites
- 39
- U.S. states
- 20
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alta Bates Comprehensive Cancer Center | Berkeley | California | 94704 | — |
| City of Hope | Duarte | California | 91010 | — |
| Scripps Clinic | La Jolla | California | 92307 | — |
| Loma Linda University Medical Center | Loma Linda | California | 92354 | — |
| Kaiser Permanente Oncology Clinical Trials | Vallejo | California | 94589 | — |
| Lombardi Cancer Center, Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| Med Star Institute, Washington Cancer Center | Washington D.C. | District of Columbia | 20010 | — |
| Hematology/Oncology Associates, PA | Jacksonville | Florida | 32207 | — |
| University of Miami | Miami | Florida | 33136 | — |
| H. Lee Moffitt Cancer Center, University of S. Florida | Tampa | Florida | 33612 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Northwestern University Medical School | Chicago | Illinois | 60611 | — |
| Loyola University Medical Center: Cardinal Bernardin Cancer Center | Maywood | Illinois | 60153 | — |
| LSU HC | Shreveport | Louisiana | 71130 | — |
| Tufts New England Medical Center | Boston | Massachusetts | 02111 | — |
| Dana-Farber Cancer Center | Boston | Massachusetts | 02115 | — |
| Beth Israel Deaconess Medical Center, Kirstein Room 135 | Boston | Massachusetts | 02215 | — |
| Department of Internal Medicine, Univ. of Michigan Comp. Cancer Center | Ann Arbor | Michigan | 48109-0922 | — |
| VA Medical Center, Sections of Hematology/Oncology | Minneapolis | Minnesota | 55417 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Hackensack University Medical Center, David Jurist Research Building | Hackensack | New Jersey | 07601 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Long Island Jewish Medical Center, Division of Hematology/Oncology | New Hyde Park | New York | 11040 | — |
| St. Vincent's Comprehensive Cancer Center, Research Department | New York | New York | 10011 | — |
| NY Presbyterian Hospital | New York | New York | 10021 | — |
| Rochester General Hospital, Lipson Cancer Blood Center | Rochester | New York | 14621 | — |
| University of Rochester Medical Center, James P. Wilmot Cancer Center | Rochester | New York | 14642 | — |
| Carolinas Hematology-Oncology Associates | Charlotte | North Carolina | 28203 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| University of Pennsylvania Cancer Center | Philadelphia | Pennsylvania | 19104 | — |
| Western Pennsylvania Hospital, Dept. of Human Oncology | Pittsburgh | Pennsylvania | 15224 | — |
| Trident Palmetto Hematology/Oncology | Charleston | South Carolina | 29406 | — |
| Division of Hematology/Stem Cell Transplant | Nashville | Tennessee | 37232-5505 | — |
| Texas Oncology at Medical City Dallas Hospital | Dallas | Texas | 75225 | — |
| Baylor Institute for Immunology Research | Dallas | Texas | 75246 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Fred Hutchinson Cancer Center | Seattle | Washington | 98109 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00048230, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 12, 2012 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00048230 live on ClinicalTrials.gov.